- Trials with a EudraCT protocol (39)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
39 result(s) found for: Health-related Quality of Life AND Diet.
Displaying page 1 of 2.
EudraCT Number: 2010-022894-32 | Sponsor Protocol Number: RG_10-209 | Start Date*: 2011-02-16 |
Sponsor Name:University of Birmingham | ||
Full Title: Dexamethasone Reduces Emesis After Major gastrointestinal Surgery (DREAMS trial) - A prospective, double-blind, multicentre, randomised control trial | ||
Medical condition: Patients undergoing nausea and vomiting following elective colorectal resections | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-004612-97 | Sponsor Protocol Number: CEC-4/CEL | Start Date*: 2021-08-12 | |||||||||||
Sponsor Name:Dr. Falk Pharma GmbH | |||||||||||||
Full Title: A phase IIb, double-blind, randomised, placebo-controlled trial to evaluate the efficacy and tolerability of ZED1227 in celiac disease subjects experiencing symptoms despite gluten-free diet | |||||||||||||
Medical condition: Treatment of celiac disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) LT (Completed) DE (Completed) NO (Completed) EE (Completed) IE (Completed) AT (Completed) FR (Completed) IT (Completed) SE (Completed) ES (Completed) PL (Completed) BG (Completed) HR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000204-11 | Sponsor Protocol Number: NN9536-4578 | Start Date*: 2021-01-11 | |||||||||||
Sponsor Name:Novo Nordisk A/S | |||||||||||||
Full Title: Effect of subcutaneous semaglutide 2.4 mg once-weekly compared to placebo in subjects with obesity and knee osteoarthritis | |||||||||||||
Medical condition: Obesity | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) DK (Completed) SE (Completed) NO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000462-41 | Sponsor Protocol Number: MTXRA | Start Date*: 2021-02-09 |
Sponsor Name:Västerbotten county | ||
Full Title: Efficacy, tolerability and preferences of peroral or subcutaneous methotrexate in patients with early rheumatoid arthritis – a randomized register based multicenter study | ||
Medical condition: Rheumatoid arthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2020-002100-39 | Sponsor Protocol Number: PTC743-MIT-001-EP | Start Date*: 2021-07-26 | ||||||||||||||||
Sponsor Name:PTC THERAPEUTICS, INC. | ||||||||||||||||||
Full Title: Efficacy and Safety Study of Vatiquinone for the Treatment of Mitochondrial Disease Subjects With Refractory Epilepsy (MIT-E) | ||||||||||||||||||
Medical condition: Genetically determined mitochondrial disease and associated refractory epilepsy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Temporarily Halted) FR (Prematurely Ended) IT (Prematurely Ended) SE (Prematurely Ended) PL (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-005601-46 | Sponsor Protocol Number: 000081 | Start Date*: 2013-05-15 | |||||||||||
Sponsor Name:Ferring International Pharmascience Center US, Inc. | |||||||||||||
Full Title: A Multicenter, Open-label, Safety and Tolerability Extension Trial of 5 mg and 10 mg Elobixibat Daily in the Treatment of Chronic Idiopathic Constipation | |||||||||||||
Medical condition: Chronic idiopathic constipation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) SE (Completed) SK (Completed) HU (Completed) CZ (Completed) GB (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000951-42 | Sponsor Protocol Number: 1517-CL-0610 | Start Date*: 2013-12-04 | |||||||||||
Sponsor Name:Astellas Pharma Europe B.V. | |||||||||||||
Full Title: A Phase 3, Randomized, Open-Label, Active-Controlled Study to Evaluate the Efficacy and Safety of Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis | |||||||||||||
Medical condition: Anemia in Chronic Kidney Disease patients not on Dialysis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) ES (Completed) NL (Completed) CZ (Completed) SK (Completed) SI (Completed) PT (Completed) AT (Completed) IE (Completed) DK (Completed) FI (Completed) LV (Completed) SE (Completed) FR (Completed) HR (Completed) HU (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012007-25 | Sponsor Protocol Number: BAY43-9006/14295 | Start Date*: 2009-10-21 | |||||||||||||||||||||
Sponsor Name:Bayer AG | |||||||||||||||||||||||
Full Title: A Double-Blind, Randomized Phase III Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer | |||||||||||||||||||||||
Medical condition: Differentiated thyroid cancer | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Completed) GB (Completed) ES (Completed) IT (Completed) NL (Completed) FR (Completed) DK (Completed) SE (Completed) BE (Completed) AT (Completed) SK (Completed) BG (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-001712-35 | Sponsor Protocol Number: N/2013/67 | Start Date*: 2015-09-01 |
Sponsor Name:Centre Hospitalier Régional Universitaire de Besançon | ||
Full Title: ANTICANCER THERAPEUTIC VACCINATION USING TELOMERASE-DERIVED UNIVERSAL CANCER PEPTIDES IN METASTATIC NON SMALL CELL LUNG CANCER | ||
Medical condition: lung cancer non-small cell | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-002269-29 | Sponsor Protocol Number: NCT-2007-11-01-1011 | Start Date*: 2008-10-06 | |||||||||||
Sponsor Name:Universitätsklinikum Heidelberg | |||||||||||||
Full Title: A prospective, randomized, double-blind, multicenter, Phase III clinical study on transarterial chemoembolisation (TACE) combined with Sorafenib vs. TACE plus placebo in patients with hepatocellula... | |||||||||||||
Medical condition: HCC without extrahepatic metastases | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005536-17 | Sponsor Protocol Number: UX007G-CL301 | Start Date*: 2017-05-17 | |||||||||||
Sponsor Name:Ultragenyx Pharmaceutical Inc | |||||||||||||
Full Title: A Phase 3, randomized, double-blind, placebo-controlled, crossover study to assess the efficacy and safety of UX007 in the treatment of movement disorders associated with Glucose Transporter Type 1... | |||||||||||||
Medical condition: Glucose Transporter Type 1 deficiency syndrome | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) ES (Prematurely Ended) FR (Completed) GB (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005163-16 | Sponsor Protocol Number: U1111-1171-4970 | Start Date*: 2016-05-30 | ||||||||||||||||
Sponsor Name:The Parker Institute, Bispebjerg and Frederiksberg Hospital, The Capital Region of Denmark | ||||||||||||||||||
Full Title: Effect of liraglutide on body weight and pain in overweight or obese patients with knee osteoarthritis. A randomised, double blind, placebo-controlled, parallel group, single-centre trial | ||||||||||||||||||
Medical condition: Adult (≥ 18 years of age) overweight or obese patients (BMI ≥ 27 kg/m2 ) above 18 years of age with knee osteoarthritis (OA) defined by clinical diagnosis of knee OA according to the American Colle... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-005180-27 | Sponsor Protocol Number: 1517-CL-0608 | Start Date*: 2013-06-24 | |||||||||||
Sponsor Name:Astellas Pharma Europe B.V. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Chronic Kidney Disease Patients not on Dialysis | |||||||||||||
Medical condition: Anemia in CKD patients not on dialysis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) BE (Completed) HU (Completed) IT (Completed) ES (Completed) BG (Completed) PL (Completed) EE (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002191-41 | Sponsor Protocol Number: AIDIT | Start Date*: Information not available in EudraCT |
Sponsor Name:Uppsala University | ||
Full Title: Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes | ||
Medical condition: Type 1 diabetes | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2015-005256-97 | Sponsor Protocol Number: SGI-110-06 | Start Date*: 2017-06-19 | |||||||||||
Sponsor Name:Astex Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 3, Multicenter, Randomized, Open-Label Study of Guadecitabine (SGI-110) versus Treatment Choice in Adults with Previously Treated Acute Myeloid Leukemia | |||||||||||||
Medical condition: Acute Myeloid Leukemia (AML) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) HU (Completed) ES (Completed) GB (Completed) FR (Completed) PL (Completed) SE (Completed) DK (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001957-29 | Sponsor Protocol Number: Brigatinib-3001 | Start Date*: 2018-12-13 | |||||||||||
Sponsor Name:ARIAD Pharmaceuticals, Inc.(a wholly-owned subsidiary of Takeda Pharmaceutical Ltd.) | |||||||||||||
Full Title: A Phase 3 Randomized Open-label Study of Brigatinib (ALUNBRIGTM) Versus Alectinib (ALECENSA®) in Advanced Anaplastic Lymphoma Kinase-Positive on–Small-Cell Lung Cancer Patients Who Have Progresse... | |||||||||||||
Medical condition: ALK positive Locally Advanced or Metastatic Non-small Cell Lung Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) SE (Completed) ES (Prematurely Ended) DE (Prematurely Ended) AT (Completed) GR (Prematurely Ended) HR (Completed) IT (Prematurely Ended) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-003220-21 | Sponsor Protocol Number: GA19/105668 | Start Date*: 2020-02-26 | |||||||||||||||||||||
Sponsor Name:University of Leeds | |||||||||||||||||||||||
Full Title: Management of diarrhoea in ulcerative colitis: multi-arm multi-stage trial of low FODMAP diet, amitriptyline, ondansetron, or loperamide: MODULATE. | |||||||||||||||||||||||
Medical condition: Diarrhoea in patients with stable ulcerative colitis. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004608-37 | Sponsor Protocol Number: FER-CARS-02 | Start Date*: 2007-07-27 | |||||||||||
Sponsor Name:Vifor Pharma, Vifor (International) Ltd. | |||||||||||||
Full Title: A randomised double-blind controlled phase III study to compare the efficacy and safety of intravenous ferric carboxymaltose (Ferinject®) with placebo in patients with chronic heart failure and iro... | |||||||||||||
Medical condition: iron deficiency in patients with chronic heart failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Completed) IT (Completed) CZ (Completed) GR (Completed) SE (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-005008-41 | Sponsor Protocol Number: 2007033 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Procter & Gamble Pharmaceuticals | |||||||||||||
Full Title: A Phase II, Randomized, Adaptive Design, Multicenter, Parallel Group, Placebo-controlled, 58-day, Dose-ranging Study of ATI-7505 in Patients with Postprandial Distress Syndrome | |||||||||||||
Medical condition: Postprandial Distress Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) BE (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003908-14 | Sponsor Protocol Number: M-2020-371 | Start Date*: 2021-07-07 | ||||||||||||||||
Sponsor Name:Miltenyi Biomedicine GmbH | ||||||||||||||||||
Full Title: A pivotal Phase II randomised, multi-centre, open-label study to evaluate the efficacy and safety of MB-CART2019.1 compared to standard of care therapy in participants with relapsed/refractory diff... | ||||||||||||||||||
Medical condition: Relapsed/refractory diffuse large B cell lymphoma (R-R DLBCL) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Trial now transitioned) LT (Trial now transitioned) AT (Trial now transitioned) NL (Trial now transitioned) BE (Trial now transitioned) DE (Trial now transitioned) IT (Trial now transitioned) ES (Ongoing) HU (Trial now transitioned) CZ (Trial now transitioned) PL (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
